Roche in-licenses Borean's Trimeric Apo A-I

Borean (Aarhus, Denmark) granted Roche (SWX:ROCZ) exclusive rights to develop and commercialize Trimeric Apo A-I to treat atherosclerosis. The trimerized version of the naturally occurring apolipoprot...